Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2 - Wikidata - wikimedia - TriplyDB

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2

http://www.wikidata.org/entity/Q36145180

about

Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic 'eat-me' signals: cleavage and inhibition of phagocytosis by Lp-PLA2 To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism Action mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studies Organization of the Mammalian Metabolome according to Organ Function, Lineage Specialization, and Longevity Impact of 8-week linoleic acid intake in soy oil on Lp-PLA2 activity in healthy adults.Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation.Lp-PLA2 Inhibitors for the Reduction of Cardiovascular Events Anti-inflammatory therapies for cardiovascular disease Anti-psoriatic therapy recovers high-density lipoprotein composition and function.Microinflammation factors in the common diseases of the heart and kidneys Apolipoprotein CIII regulates lipoprotein-associated phospholipase A2 expression via the MAPK and NFκB pathways.Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort.The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease.Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults.Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome.Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies.Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes.Emerging anti-inflammatory drugs for atherosclerosis.Novel metabolic biomarkers of cardiovascular disease.New and emerging biomarkers in cardiovascular disease.Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection.ω3-polyunsaturated fatty acids suppress lipoprotein-associated phospholipase A2 expression in macrophages and animal models.Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor.Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis.The putative phospholipase Lip2 counteracts oxidative damage and influences the virulence of Ustilago maydis.Evaluation of carotid intima-media thickness and carotid arterial stiffness in children with adenotonsillar hypertrophy.The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice.Unraveling the PAF-AH/Lp-PLA2 controversy.New lipid and lipoprotein targets for the treatment of cardiometabolic diseases.The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression.Resveratrol suppresses lipoprotein-associated phospholipase A2 expression by reducing oxidative stress in macrophages and animal models.Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.

P2860

Q23923069-AC12B656-5428-4257-9678-199A18886C81 Q26865969-2F46FCC5-9FAC-4D0E-9914-1F1E078E3056 Q28072835-C0444563-919B-45E8-8343-0996ED9BE025 Q28077812-A0F50943-CA4D-4727-95CE-6B261133B519 Q28604105-CFD7F667-6382-495D-8B4A-20FEF60B1240 Q33651282-6C769821-BB8A-4043-8231-466F5CBF7D0B Q33696583-6D796683-0667-429A-A07D-B91993E6E43C Q33936097-7178F656-0881-4DEA-AE85-06235D43DD62 Q34137872-36D77B4C-C529-42A4-AC6C-248F97D5A806 Q34259215-AC598074-04BC-4173-BFB3-E1E76B037B58 Q35025893-647BA3BD-50D5-44B5-8879-65099F5BD1EC Q35616605-B41DB60E-57BE-4618-98E6-F9494D53B0E1 Q35856590-B057B682-3F2B-4A59-A3EE-644E33D2EA66 Q35879822-268789F4-4005-4DB9-87C6-34D217BA55B5 Q35927066-6A4E1B93-C4E2-46CC-A26B-9BE6E3D9E242 Q36933725-771213A8-F822-4991-9E22-59FDC8DC03B0 Q37112920-98828229-13A2-4AFA-8B3D-790ECCE0DCBD Q37401167-79769801-31B4-4BBB-8896-3667754DA4CD Q37431606-5D3EDA85-C485-46C3-889F-E5DDB1D4E456 Q37713531-80FBAA09-A53D-4373-8726-287007CCA587 Q37720776-08D939FF-EC7B-4217-A4D7-4684C4280CBE Q38103488-189AC852-3D9C-44D1-8DC7-FF835989A92A Q38106998-26758C31-A8A6-41C1-9AAD-DD267DCC785D Q38245327-9B84FCE1-F145-49F9-828A-078D02C61FD3 Q38586900-E1846B87-BBC2-471A-B055-5CC9419A8CFD Q38682093-AFEEF47B-2C23-4335-8934-D4D4B8C53CF9 Q38707328-4D7E502C-EA71-422C-8623-05EA60D7EB19 Q38870156-616F3928-D622-4A61-A495-433E442C271B Q39011074-6BC13160-89A3-4DB1-9931-BAA56E9D1709 Q39153624-ADD0DFF3-D635-4C76-B9D1-0FBB07EBE3DF Q40328826-2DC4CB34-F0F0-4D30-BF77-DD722689FE5A Q40765119-8FE0FFF5-15A0-46B2-A4DD-39C7D3266120 Q40865332-3B813741-D7F7-436E-AF82-B7D29381CA65 Q42755958-38648EED-B95C-4312-A667-9481E61DA00E Q43204699-948EC38B-C223-4FAE-9895-2D5C804A6256 Q43237185-CE380384-B153-4454-BC1B-E1C9BB7D9546 Q44819479-A6649A9F-FB5C-48BB-AA44-ECE2197E8EAD Q46290391-63230CF3-956B-49F9-B530-2289B33B6F60 Q46352015-C52C052A-6D7F-4D9F-9B79-0935911C9073 Q46590378-9DDD7F1F-5619-41E3-82CA-9EAC2E766EDA

P2860

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2

http://www.wikidata.org/entity/Q36145180

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Modulation of oxidative stress ...... in-associated phospholipase A2

@ast

Modulation of oxidative stress ...... in-associated phospholipase A2

@en

type

label

Modulation of oxidative stress ...... in-associated phospholipase A2

@ast

Modulation of oxidative stress ...... in-associated phospholipase A2

@en

prefLabel

Modulation of oxidative stress ...... in-associated phospholipase A2

@ast

Modulation of oxidative stress ...... in-associated phospholipase A2

@en

P1433

Q36145180-B9B27115-05D7-4445-A7D7-456C63B0FEC5

P1476

Q36145180-BE3336EB-109A-4B1A-BA8E-6AB08E3038E7

P2093

Q36145180-D42D8A81-F90B-43F7-B97D-90941DB003BD

Q36145180-F3894DE4-566F-4EDC-B223-7124A1835599

P2860

Q36145180-00BAC8BD-1FC1-4B96-BD46-F66B47BE6456

Q36145180-042DA49B-1E7B-4CEC-888A-0DF112D1B767

Q36145180-08E40288-399B-4C42-9A0F-D9B5A43F17F6

Q36145180-0FD880FC-31A0-4F52-9EF2-388FC7C030F4

Q36145180-0FD9D5C6-C016-4B49-9669-EF4FEB356D10

Q36145180-123D2287-A542-401B-BE43-0B13BD7BC589

Q36145180-1426F25A-10C3-4DEA-8CBD-6CAE63AD0A38

Q36145180-187C8CD7-12E0-4626-9C17-318C471FC245

Q36145180-18E8BD23-20F1-4507-8844-ACF0D4DC2859

Q36145180-1D70A947-0AAB-4608-A2A1-999E89B42D01

P304

Q36145180-CDE64231-EE71-4CAA-9AF7-6F0AC99B6660

P31

Q36145180-1A7138EB-203D-4CA0-ADAD-AF91E7047F98

P356

Q36145180-DCBF28AE-A677-4046-AB2C-F3808008C7A7

P433

Q36145180-83FD06B7-D1F4-4845-8E6B-F620ACD7FDFA

P478

Q36145180-6EBDAE4E-CDB7-4C36-A10D-33054C2BBF54

P577

Q36145180-4A782A45-FD30-4611-AD8D-2E6173ADEA1A

P698

Q36145180-CF6F3515-2E07-4705-A534-61D0E5E78D47

P921

Q36145180-F4BBE7C0-21FE-4311-AC8C-8D177986FD44

P932

Q36145180-A1C2FBB8-C452-4480-ADEB-BA24AC8535BE

P356

P1433

Journal of Lipid Research

P1476

Modulation of oxidative stress ...... in-associated phospholipase A2

@en

P2093

Diana M Stafforini

http://www.w3.org/2001/XMLSchema#string

Robert S Rosenson

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of plasma unsaturated lysophosphatidylcholines in human and rat

The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

Atherosclerosis

Crystal Structure of Human Plasma Platelet-activating Factor Acetylhydrolase: STRUCTURAL IMPLICATION TO LIPOPROTEIN BINDING AND CATALYSIS

Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression

Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation

Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A

P304

1767-1782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.R024190

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22665167

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3413219

http://www.w3.org/2001/XMLSchema#string